loader
Home
Anastasios Lymperopoulos

EDITORIAL BOARD MEMBER - Anastasios Lymperopoulos


Anastasios Lymperopoulos

Nova Southeastern University USA

BIOGRAPHY:

My career started by earning M.Sc. in Medicinal Chemistry followed by Ph.D. in Pharmacology, after graduating from the School of Pharmacy of the University of Patras, Greece. Its major turning point was in 2004, when I joined the lab of Dr. Walter Koch, a former postdoctoral fellow of Nobel laureate Professor Robert Lefkowitz`s lab at Duke University. During my 5-year postdoctoral tenure there, I had several successes, awards and honors, most prominent among which being a lead-author publication in Nature Medicine and a 4-year Scientist Development Grant award by the American Heart Association (AHA) I currently hold. In addition, I have been a post-doctoral research fellow of the AHA for a total of three years in the past, and, in fact, my postdoctoral fellowship application with AHA in 2007 got an unusual 1-year extension based on its exceptionally high score. I have also been a finalist for the AHA-sponsored Melvin L. Marcus Young Investigator Award in Basic Cardiovascular Sciences, and for the Cardiovascular Research Award of the Council on Basic Cardiovascular Sciences of the European Society of Cardiology (ESC), I hold two (provisional) research patents, and I currently serve on the Editorial Boards of two peer-reviewed journals, as a regular peer-reviewer for several prestigious journals, including British Journal of Pharmacology, "Circulation Research", and American Journal of Cardiology, and as a research grant reviewer for AHA. In addition, I am an elected Fellow of the American Heart Association (FAHA) and its Council on Basic Cardiovascular Sciences (BCVS). Finally, I have published in various prestigious scientific journals, in addition to Nature Medicine, such as: Circulation, JACC, PNAS, JBC, Molecular Pharmacology, etc., and my papers are highly cited.

RESEARCH INTERESTS:

Cardiovascular biology/pharmacology and gene therapy, with a particular interest in mechanisms of adrenergic system regulation in heart failure and in ways of manipulating these mechanisms for therapeutic purposes